Asset Management One’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.9M Sell
677,731
-100,645
-13% -$5.47M 0.07% 227
2026
Q1
$48.8M Sell
778,376
-100,729
-11% -$8.06M 0.14% 126
2025
Q4
$84.1M Buy
879,105
+103,326
+13% +$10.1M 0.23% 79
2025
Q3
$75.7M Buy
775,779
+7,745
+1% +$802K 0.22% 82
2025
Q2
$82.5M Buy
768,034
+32,834
+4% +$3.32M 0.26% 75
2025
Q1
$74.2M Buy
735,200
+39,076
+6% +$3.93M 0.26% 74
2024
Q4
$63.1M Buy
696,124
+53,471
+8% +$4.71M 0.22% 84
2024
Q3
$53.9M Buy
642,653
+6,005
+0.9% +$473K 0.19% 97
2024
Q2
$49M Sell
636,648
-16,782
-3% -$1.23M 0.19% 99
2024
Q1
$44.8M Sell
653,430
-26,262
-4% -$1.69M 0.17% 115
2023
Q4
$38.3M Buy
679,692
+10,948
+2% +$584K 0.15% 129
2023
Q3
$35.3M Sell
668,744
-1,278
-0.2% -$67K 0.16% 121
2023
Q2
$36.2M Buy
670,022
+9,382
+1% +$490K 0.15% 127
2023
Q1
$33.1M Buy
660,640
+16,525
+3% +$779K 0.15% 140
2022
Q4
$29.9M Sell
644,115
-19,097
-3% -$827K 0.15% 147
2022
Q3
$25.7M Buy
663,212
+17,296
+3% +$694K 0.13% 158
2022
Q2
$24.1M Buy
645,916
+3,639
+0.6% +$148K 0.11% 177
2022
Q1
$28.4M Sell
642,277
-27,788
-4% -$1.2M 0.11% 180
2021
Q4
$28.9M Sell
670,065
-4,383
-0.6% -$184K 0.1% 201
2021
Q3
$29.3M Sell
674,448
-6,703
-1% -$297K 0.11% 184
2021
Q2
$29.1M Sell
681,151
-21,216
-3% -$893K 0.11% 188
2021
Q1
$27.1M Sell
702,367
-32,161
-4% -$1.22M 0.11% 187
2020
Q4
$26.1M Sell
734,528
-9,364
-1% -$337K 0.11% 190
2020
Q3
$28.4M Buy
743,892
+22,446
+3% +$865K 0.13% 158
2020
Q2
$25.3M Sell
721,446
-40,132
-5% -$1.45M 0.12% 171
2020
Q1
$24.9M Buy
761,578
+1,308
+0.2% +$51.1K 0.15% 153
2019
Q4
$34.4M Buy
760,270
+20,737
+3% +$868K 0.16% 139
2019
Q3
$30.1M Sell
739,533
-10,439
-1% -$442K 0.15% 154
2019
Q2
$32.2M Buy
749,972
+26,505
+4% +$1.02M 0.16% 134
2019
Q1
$27.8M Sell
723,467
-1,564,271
-68% -$59.7M 0.15% 144
2018
Q4
$80.7M Buy
2,287,738
+32,654
+1% +$1.18M 0.19% 115
2018
Q3
$86.8M Buy
2,255,084
+15,468
+0.7% +$540K 0.18% 124
2018
Q2
$73.2M Buy
2,239,616
+62,001
+3% +$1.87M 0.16% 141
2018
Q1
$59.5M Buy
2,177,615
+6,099
+0.3% +$166K 0.13% 178
2017
Q4
$53.9M Sell
2,171,516
-17,781
-0.8% -$490K 0.12% 192
2017
Q3
$63.8M Buy
2,189,297
+4,651
+0.2% +$128K 0.15% 157
2017
Q2
$60.6M Buy
2,184,646
+11,869
+0.5% +$315K 0.15% 152
2017
Q1
$54M Sell
2,172,777
-128,012
-6% -$3.11M 0.14% 162
2016
Q4
$49.8M Buy
2,300,789
+1,490,157
+184% +$32.5M 0.13% 180
2016
Q3
$18.9M Buy
810,632
+11,513
+1% +$275K 0.28% 77
2016
Q2
$18.4M Sell
799,119
-380,688
-32% -$8.24M 0.28% 85
2016
Q1
$22.2M Buy
1,179,807
+16,193
+1% +$284K 0.32% 64
2015
Q4
$21.8M Buy
1,163,614
+20,530
+2% +$368K 0.33% 64
2015
Q3
$18.3M Buy
1,143,084
+47,357
+4% +$809K 0.28% 77
2015
Q2
$19.5M Sell
1,095,727
-181,846
-14% -$3.25M 0.27% 75
2015
Q1
$23.1M Sell
1,277,573
-41,363
-3% -$654K 0.29% 68
2014
Q4
$17.5M Buy
1,318,936
+1,152,575
+693% +$14.7M 0.23% 99
2014
Q3
$1.98M Sell
166,361
-26,214
-14% -$330K 0.03% 612
2014
Q2
$2.46M Buy
192,575
+42,640
+28% +$554K 0.04% 493
2014
Q1
$1.98M Sell
149,935
-17,284
-10% -$227K 0.03% 517
2013
Q4
$2.02M Sell
167,219
-17,786
-10% -$210K 0.03% 523
2013
Q3
$2.13M Buy
185,005
+17,891
+11% +$194K 0.03% 509
2013
Q2
$1.54M Buy
+167,114
New +$1.42M 0.03% 560

Other funds holding BSX

Asset Management One's BSX Position: Q2 2026 in Review

Asset Management One reduced its Boston Scientific (BSX) stake by 13% in Q2 2026, selling an estimated $5.47M and leaving 677,731 shares worth $28.9M. The position accounts for 0.07% of the portfolio, ranked #227.

Asset Management One first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $86.8M in Q3 2018. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Asset Management One held 677,731 shares of Boston Scientific worth $28.9M as of Q2 2026.
  • Asset Management One sold 100,645 Boston Scientific shares in Q2 2026, an estimated $5.47M.
  • Boston Scientific made up 0.07% of Asset Management One's portfolio in Q2 2026, its #227 holding.
  • Asset Management One first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
  • Asset Management One's Boston Scientific position peaked at $86.8M in Q3 2018.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Asset Management One's 13F filing for Q2 2026, filed 28 Jul 2026.